Your browser doesn't support javascript.
loading
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
Nyanhete, Tinashe E; Edwards, Robert J; LaBranche, Celia C; Mansouri, Katayoun; Eaton, Amanda; Dennison, S Moses; Saunders, Kevin O; Goodman, Derrick; Janowska, Katarzyna; Spreng, Rachel L; Zhang, Lu; Mudrak, Sarah V; Hope, Thomas J; Hora, Bhavna; Bradley, Todd; Georgiev, Ivelin S; Montefiori, David C; Acharya, Priyamvada; Tomaras, Georgia D.
Afiliação
  • Nyanhete TE; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.
  • Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • LaBranche CC; Department of Immunology, Duke University School of Medicine, Durham, NC, United States.
  • Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Eaton A; Department of Medicine, Duke University School of Medicine, Durham, NC, United States.
  • Dennison SM; Department of Surgery, Duke University School of Medicine, Durham, NC, United States.
  • Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Goodman D; Department of Surgery, Duke University School of Medicine, Durham, NC, United States.
  • Janowska K; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.
  • Spreng RL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Zhang L; Department of Surgery, Duke University School of Medicine, Durham, NC, United States.
  • Mudrak SV; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Hope TJ; Department of Surgery, Duke University School of Medicine, Durham, NC, United States.
  • Hora B; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.
  • Bradley T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Georgiev IS; Department of Surgery, Duke University School of Medicine, Durham, NC, United States.
  • Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
  • Acharya P; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.
  • Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.
Front Immunol ; 12: 670561, 2021.
Article em En | MEDLINE | ID: mdl-35003053
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Viremia / Anticorpos Anti-HIV / Antígenos CD4 / Proteína gp120 do Envelope de HIV / Infecções por HIV / HIV-1 / Sobreviventes / Anticorpos Amplamente Neutralizantes / Epitopos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Viremia / Anticorpos Anti-HIV / Antígenos CD4 / Proteína gp120 do Envelope de HIV / Infecções por HIV / HIV-1 / Sobreviventes / Anticorpos Amplamente Neutralizantes / Epitopos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article